Hydroxyproline-based DNA mimics provide an efficient gene silencing in vitro and in vivo
Open Access
- 28 April 2006
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 34 (8) , 2247-2257
- https://doi.org/10.1093/nar/gkl249
Abstract
To be effective, antisense molecules should be stable in biological fluids, non-toxic, form stable and specific duplexes with target RNAs and readily penetrate through cell membranes without non-specific effects on cell function. We report herein that negatively charged DNA mimics representing chiral analogues of peptide nucleic acids with a constrained trans-4-hydroxy-N-acetylpyrrolidine-2-phosphonate backbone (pHypNAs) meet these criteria. To demonstrate this, we compared silencing potency of these compounds with that of previously evaluated as efficient gene knockdown molecules hetero-oligomers consisting of alternating phosphono-PNA monomers and PNA-like monomers based on trans-4-hydroxy-L-proline (HypNA-pPNAs). Antisense potential of pHypNA mimics was confirmed in a cell-free translation assay with firefly luciferase as well as in a living cell assay with green fluorescent protein. In both cases, the pHypNA antisense oligomers provided a specific knockdown of a target protein production. Confocal microscopy showed that pHypNAs, when transfected into living cells, demonstrated efficient cellular uptake with distribution in the cytosol and nucleus. Also, the high potency of pHypNAs for down-regulation of Ras-like GTPase Ras-dva in Xenopus embryos was demonstrated in comparison with phosphorodiamidate morpholino oligomers. Therefore, our data suggest that pHypNAs are novel antisense agents with potential widespread in vitro and in vivo applications in basic research involving live cells and intact organisms.Keywords
This publication has 32 references indexed in Scilit:
- Genome‐wide application of RNAi to the discovery of potential drug targetsFEBS Letters, 2005
- The therapeutic potential of RNA interferenceFEBS Letters, 2005
- Sequence Specificity of Alternating Hydroyprolyl/phosphono Peptide Nucleic Acids against Zebrafish Embryo mRNAsJournal of Drug Targeting, 2004
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004
- Oligonucleotide‐Based Knockdown Technologies: Antisense Versus RNA InterferenceChemBioChem, 2003
- A Specificity Comparison of Four Antisense Types: Morpholino, 2′-O-Methyl RNA, DNA, and Phosphorothioate DNAAntisense and Nucleic Acid Drug Development, 1997
- Morpholino Antisense Oligomers: Design, Preparation, and PropertiesAntisense and Nucleic Acid Drug Development, 1997
- Morpholino and Phosphorothioate Antisense Oligomers Compared in Cell-Free and In-Cell SystemsAntisense and Nucleic Acid Drug Development, 1997
- PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rulesNature, 1993
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991